Custom treatment plans prescribed by licensed U.S. physicians and shipped to your door
ConfirmedStated on the homepage. We confirmed this ourselves.
Where the vendor states thisTelehealth GLP-1 prescriptions
A Dallas telehealth company selling compounded and prescription treatments across weight loss, sexual health, testosterone, hair, skin, peptides and menopause. FDA issued it a warning letter in February 2026 over how it marketed compounded semaglutide and tirzepatide.
We may earn a commission if you buy through the links to Strut Health on this page, at no extra cost to you. That does not change how we grade or rank it, and Strut Health did not write or approve this review.

quality claims we could confirm ourselves, rather than repeat from the vendor's marketing.
Compounded semaglutide, oral and injectable sermorelin, tadalafil and other sexual health drugs, tretinoin, dutasteride topicals and more.
Everything here is a prescription service that starts with a licensed clinician's review of your own health information. Compounded medications are made by a pharmacy against a prescription and are not FDA-approved or reviewed by the FDA for safety, effectiveness or quality. This entry describes what the brand offers and what we could check. It is not medical advice and not a recommendation to use it.
Every telehealth brand we rank gets the same five checks, read from its public pages on September 24, 2026. "Not met" means we did not find it, or the terms say otherwise, on the pages we could read. Price and commission play no part.
Shows 'starting at $149' on auto-refill and no regular price.
Its terms name Titan Health, P.A. and Titan Medical Group as the clinical provider.
Shows an accreditation badge for a compounding pharmacy but never names the pharmacy.
Its refund policy says no refunds once the pharmacy has processed an order.
FDA warning letter 721448 to Strut Health, LLC, dated February 20, 2026.
Graded by whether we could confirm it ourselves or are only repeating what the vendor states. A vendor's honesty about its own testing is a different question from what a published trial shows, so this is a separate scale from the evidence grades on our guides.
Stated on the homepage. We confirmed this ourselves.
Where the vendor states thisThe semaglutide product page shows 'starting at $149' on auto-refill with a 13% saving. We confirmed this ourselves.
Where the vendor states thisStated on the how-it-works page. We confirmed this ourselves.
Where the vendor states thisWe read warning letter 721448 on fda.gov. It says the labels pictured on Strut's site suggested Strut compounds its semaglutide and tirzepatide when it does not, and quotes the phrases 'Generic Zepbound, Mounjaro' and 'the active ingredient in the brand medications', which FDA says imply approval that compounded drugs do not have. It is an FDA allegation, not a court ruling, and we have not checked whether the wording is still on the site. We will update this entry if FDA closes the letter out.
FDA does not review compounded drugs for safety, effectiveness or quality before they are sold. In 2026 FDA warned 30 telehealth companies over claims implying sameness with approved drugs, and proposed excluding semaglutide, tirzepatide and liraglutide from the 503B bulks list, so the legal footing of this category can change.
Selling everything from ED drugs to peptides means the GLP-1 program is one product line among many.
Yes. FDA published warning letter 721448 to Strut Health, LLC on fda.gov, dated February 20, 2026. It concerns misleading claims about compounded semaglutide and tirzepatide.
Every fact above traces to one of these pages, published by the vendor itself and checked on September 20, 2026. Vendor policy pages change without notice, so if something here looks out of date, it probably is.
Compare against
Open pricing, public COAs, strict research-only gate